Lanreotide Acetate manufacturers and suppliers

Lanreotide Acetate suppliers

Lanreotide Acetate

CAS:: 127984-74-1

MF:: C54H69N11O10S2

MW:: 0

Suppliers by country/region

Company Type

Properties

Melting point:: >165°C (dec.)

storage temp.: -20°C

solubility: DMSO (Slightly), Methanol (Slightly)

form: powder

color: white to off-white

InChIKey: PUDHBTGHUJUUFI-UHFFFAOYSA-N

SMILES: S1CC(NC(=O)C(N)CC2=CC=C3C(=C2)C=CC=C3)C(=O)NC(CC2=CC=C(O)C=C2)C(=O)NC(CC2C3=C(NC=2)C=CC=C3)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(C(NC(C(=O)N)C(O)C)=O)CS1

Safety Information

Symbol(GHS): GHS08

Signal word: Warning

Hazard statements: H361

Precautionary statements: P281

Hazard Codes: Xn

Risk Statements: 63

Safety Statements: 36/37

WGK Germany: 3

Use

Lanreotide acetate, an octapeptide somatostatin analog, reached its first worldwide market in France for acromegaly when surgery or radiotherapy have failed to restore normal growth hormone secretion. Lanreotide is a selective inhibitor of growth hormone and reduces the secretion of growth hormone, thyrotropin, motilin and pancreatic polypeptide in humans. Lanreotide has antiproliferative properties and is reportedly in clinical trials for the prevention of restenosis following coronary artery angioplasty, for diabetic retinopathy, and as a therapy for psoriasis. Its potential for neuroendocrine tumors and hormone-responsive prostate cancer has also been demonstrated.

You can find Lanreotide Acetate suppliers, manufacturers, and distributors from countries such as China, United States and the India here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.